VTRS
Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-inputs (vergelijkbare managers):
breedte van houders -12.0% ·
aandelenstroom +1.9% ·
netto nieuwe posities -18.2%
· formule
Geconcentreerde accumulatie: stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 10.99M | $194.70M | n/a | −2 |
| Q2 2026 | 148 | -1 | 754.00M | $11.97B | +6 | −8 |
| Q1 2026 | 153 | +6 | 683.49M | $9.23B | +9 | −4 |
| Q4 2025 | 146 | -3 | 743.40M | $9.25B | +1 | −3 |
| Q3 2025 | 22 | -3 | 488.65M | $4.84B | n/a | −4 |
| Q2 2025 | 23 | +2 | 455.87M | $4.07B | +3 | −1 |
| Q1 2025 | 18 | -1 | 210.93M | $1.84B | +1 | −2 |
| Q4 2024 | 19 | -3 | 200.96M | $2.50B | +1 | −4 |
| Q3 2024 | 21 | +3 | 124.36M | $1.44B | +3 | n/a |
| Q2 2024 | 18 | n/a | 121.66M | $1.29B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 140.27M | -3.3% | $1.39B | 0.0% | ▼ Trim | 2 | SEC ↗ ×7 |
| 2 | T. Rowe Price ✦ | 84.06M | +6.7% | $832.24M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 3 | BlackRock ✦ (passief) | 81.96M | -1.1% | $811.40M | 0.0% | ▼ Trim | 2 | SEC ↗ ×21 |
| 4 | State Street Global Advisors ✦ (passief) | 55.71M | +0.8% | $551.50M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passief) | 29.92M | -4.2% | $295.62M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | Morgan Stanley ✦ | 16.58M | n/a | $164.10M | 0.0% | n/c | 1 | SEC ↗ ×15 |
| 7 | JPMorgan Chase ✦ | 13.31M | n/a | $131.78M | 0.0% | n/c | 1 | SEC ↗ ×30 |
| 8 | Fidelity (FMR) ✦ | 11.05M | +62.6% | $109.35M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 9 | Citadel Advisors ✦ | 10.47M | +40.9% | $103.62M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Arrowstreet Capital ✦ | 8.85M | +17.6% | $87.64M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 11 | Glenview Capital ✦ | 8.25M | 0.0% | $81.65M | 2.0% | Held | 6 | SEC ↗ |
| 12 | Millennium Management ✦ | 6.84M | -10.8% | $67.74M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 6.06M | +30.0% | $60.04M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 14 | Goldman Sachs Group ✦ | 5.48M | n/a | $54.26M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 15 | AQR Capital Management ✦ | 3.95M | +23.1% | $38.32M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 16 | Gotham Asset Management ✦ | 3.35M | +23.7% | $33.17M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 1.51M | +342.9% | $14.97M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 367.14K | -23.6% | $3.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Marshall Wace ✦ | 316.67K | -45.4% | $3.14M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 20 | GAMCO Investors ✦ | 287.99K | -2.1% | $2.85M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | Point72 Asset Management ✦ | 39.89K | -95.8% | $394,951 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | Fisher Asset Management ✦ | 11.73K | +12.4% | $116,155 | 0.0% | ▲ Add | 6 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Norges Bank | $103.09M | was 0.0% |
| Capital World Investors | $988,355 | was 0.0% |
| Two Sigma Investments | $230,251 | was 0.0% |
| Soros Fund Management | $109,866 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,011 houders, 984.50M aandelen, $12.02B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.